Chagrin Falls, OH – According to filings with the U.S. Securities and Exchange Commission, Okapi Medical is raising $3,750,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Darren Obrigkeit played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Okapi Medical
Okapi Medical: Developers of the Noninvasive Wound Closure Platform. Okapi Medical is developing a unique line of noninvasive skin closure devices. Okapi’s proprietary adhesive, Cutiva, offers physicians with the most advanced method for simple, safe, and secure closures. Cutiva will offer a more comfortable option versus suturing, fewer wound complications, a secure bacterial barrier, and time and cost savings to providers.

To learn more about Okapi Medical, visit http://okapimed.com/

Contact:
Darren Obrigkeit, Chief Executive Officer
440-279-8091
https://www.linkedin.com/in/darrenobrigkeit/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved